Jordan Leef
Jordan Leef is an entrepreneur and venture capitalist specializing in the healthcare industry. Jordan brings more than a decade of experience in life science venture creation and has served on the boards of over 20 companies as a director or observer.
Jordan most recently served as an executive at two oncology companies, Metamark Genetics, which focused on urological cancers, and Interpace Diagnostics Group (Nasdaq: IDXG), which develops molecular diagnostic tests. He was also a Principal Venture Capitalist and member of the healthcare investment team at the publicly-traded venture capital firm, Safeguard Scientifics (NYSE: SFE).
Prior to Safeguard, Jordan served as a Senior Associate with MentorTech Ventures, a Philadelphia-based venture capital firm that invests in seed and early-stage companies. During his time at MentorTech, Jordan was also a Senior Associate for SVM Israel, investing in Israeli private equity and venture capital funds as well as selectively co-investing alongside those funds. Earlier in his investment career, Jordan was a Financial Analyst at the private equity firm Pharos Capital Group, where he worked as a member of the investment team to provide growth and later-stage capital for businesses in the healthcare, business services and technology industries.
Before his career in venture capital, Jordan worked in the biotechnology equity research group at C.E. Unterberg,
Towbin (presently known as Collin Stewart) and for Pfizer, Inc. (NYSE: PFE) in its US clinical operations and business development divisions.
Jordan Leef is a graduate of the Wharton School at the University of Pennsylvania, where he concentrated in healthcare management and policy.